Hair Transplant Statistics: 2026 Report

Hair transplant graft survival rates range from 90 to 95% at accredited, physician-led clinics, and the global market reached $7.8 billion in 2026, driven largely by FUE procedures now accounting for roughly 65% of global volume. This report compiles data from clinical studies, industry census data, and market research to give you a factual benchmark across prevalence, procedure volume, outcomes, and recovery timelines.

Key Takeaways

  • The global hair transplant services market reached $7.8 billion in 2026.
  • Androgenetic alopecia affects an estimated 50 million men and 30 million women in the United States.
  • FUE procedures command approximately 65% of global procedure volume in 2026.
  • Graft survival rates at accredited, physician-led clinics range from 90 to 95%.
  • Two-thirds of American men show noticeable hair loss by age 35.
  • 90% of patients cite “feeling more attractive” as their primary reason for undergoing a transplant (ISHRS 2025 Census).
  • Repair procedures rose to 6.9% of all transplants in 2024, up from 5.4% in 2021, largely driven by black-market procedures.

Hair Loss Prevalence by Age and Gender

Androgenetic alopecia, commonly called pattern hair loss, drives the overwhelming majority of hair transplant consultations. It affects an estimated 50 million men and 30 million women in the United States (MedlinePlus Genetics). The condition intensifies with age, but it often starts earlier than most patients expect. Androgenetic alopecia accounts for more than 95% of hair loss in men (American Hair Loss Association). Among women, pattern hair loss affects approximately 12% of those between ages 20 and 29, rising to around 40% by age 50 (Li & Iyengar, PMC 2025). The table below shows prevalence estimates across age groups.

Age group Male prevalence Female prevalence
20–29 ~16% ~12%
30–39 ~30% ~17%
40–49 ~53% ~28%
50+ ~85% ~40%
By age 65 ~53% (baldness) ~37% (baldness)

Sources: MedlinePlus Genetics; American Hair Loss Association; Li & Iyengar, PMC, 2025; NCOA.

Key Insights

  • Most patients sought treatment before reaching advanced stages of hair loss.
  • Most men and women seek care between ages 25 and 40.
  • The data reflect a shift toward proactive hair loss management, with patients seeking treatment earlier rather than waiting until hair loss becomes severe.

Procedure Volume and Technique Breakdown

The global hair transplant services market reached an estimated $7.8 billion in 2026, up from $7.4 billion in 2025, and projects a 5% compound annual growth rate through 2036 (Fact.MR). North America holds the largest regional share. The United States alone generated approximately $2.9 billion in 2025 revenue.

FUE (Follicular Unit Extraction) dominates global procedure volume. FUT (Follicular Unit Transplantation) remains in active clinical use, particularly for larger cases requiring maximum graft yield from a single session, but it holds a smaller share of total volume.

Metric FUE FUT
Global procedure share (2026) ~65% ~9–14%
Average grafts per session (2024) 2,262 2,100
Patients achieving goal in one session 67%
Recovery time 5–7 days 10–14 days
Scarring type Minimal (punctate) Linear
Density achievable 30–40 grafts/cm² 30–40 grafts/cm²

Sources: Fact.MR; International Society of Hair Restoration Surgery, 2025 Practice Census; Vera Clinic Academy Database.

Key Insights

  • Men remain the primary patient group, accounting for approximately 80–85% of global hair restoration procedures.
  • Female patient demand is increasing, reflecting broader awareness and acceptance of hair restoration options.
  • More younger first-time patients are seeking treatment, signaling a shift toward hair restoration as a planned, proactive medical decision rather than a reactive last resort.

Graft Survival Rates by Clinic Type

Graft survival is the most clinically meaningful measure of transplant quality. It measures the percentage of transplanted follicles that successfully establish blood supply and produce permanent terminal hair, assessed at 12 to 18 months post-procedure. Outcome data show a wide spread depending on who performs the procedure and how.

Clinic type Graft survival rate Patient satisfaction at 12 months
Accredited, physician-performed 90–95% 90–98%
Elite surgeon-led centers 95–98% ~98%
Unaccredited or technician-led 70–85% Below published benchmarks
Black-market or unregulated As low as 70% Not reliably reported

Sources: International Society of Hair Restoration Surgery, 2025 Practice Census; Charles Medical Group, 2026.

Key Insights

  • Clinic quality has lasting consequences. Patients have a finite lifetime donor supply (about 6,000 grafts), so poorly performed procedures can permanently waste grafts and increase the need for corrective surgery.
  • Repair procedures and black-market clinics are increasing. Repair surgeries rose from 5.4% of all transplants in 2021 to 6.9% in 2024, while 59% of ISHRS members reported black-market clinics operating in their cities, up from 51% in 2021.
  • Adjunctive therapies can improve outcomes. A 2024 study found that 90% of patients receiving PRP plus FUE achieved moderate-to-high-density graft survival, compared with 60% for FUE alone.

Post-Procedure Outcome Timeline

Hair transplant results do not appear immediately. The biological recovery process follows a predictable sequence, and understanding it prevents misreading early shock loss, a normal phase in which transplanted hairs shed before re-entering the growth cycle.

Milestone Timeline What to expect
Graft anchoring Days 1–3 Redness, tenderness, early scab formation
Shock loss (shedding phase) Weeks 2–4 Transplanted hairs shed; this is expected and normal
Initial regrowth Months 3–4 Fine, thin hairs emerge
Meaningful density increase Months 5–6 Coverage visibly improves; styling becomes easier
Near-final result Months 10–12 90–98% of surviving grafts active and growing
Full maturation Months 12–18 Texture and caliber normalize; final density achieved

Source: Focus Digital Research Study, Hair Transplant Industry Benchmarks, 2026.

Key Insights

  • The 12-month mark is the clinical benchmark for evaluating the success of a hair transplant, with most patients reaching their primary outcome by this point.
  • Long-term satisfaction remains high among patients who follow recommended post-operative care and medication protocols.
  • Ongoing hair loss management matters. Patients who did not adhere to prescribed medications experienced a 4–6% decline in hair density over five years, highlighting the importance of maintenance therapy after transplantation.

About This Report

This report was prepared for the Center for Hair Transplantation. For a PDF copy of the report, contact us here.

Further Reading

Sources